Research in the heart of hematology: chronic myeloid leukemia 2017
One of the great success stories of modern hematology is reaching its next and possibly final phase: the achievement of treatment-free remissions in stable deep molecular responders with chronic myeloid leukemia (CML) which may well be equivalent to cure. Although only the minority of patients
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
Haematologica
Year: 2017, Volume: 102, Issue: 3, Pages: 418-421 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2016.159848 |
| Online Access: | Verlag, kostenfrei registrierungspflichtig, Volltext: http://dx.doi.org/10.3324/haematol.2016.159848 Verlag, kostenfrei registrierungspflichtig, Volltext: http://www.haematologica.org/content/102/3/418 
|
| Author Notes: | Rüdiger Hehlmann |
| Summary: | One of the great success stories of modern hematology is reaching its next and possibly final phase: the achievement of treatment-free remissions in stable deep molecular responders with chronic myeloid leukemia (CML) which may well be equivalent to cure. Although only the minority of patients |
|---|---|
| Item Description: | Gesehen am 09.04.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2016.159848 |